News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Howard D. Edington, MD

Articles by Howard D. Edington, MD

Howard D. Edington, MD

Dr. Edington on the Utilization of TVEC Therapy in Melanoma

ByHoward D. Edington, MD

April 28th 2022

Howard D. Edington, MD, discusses the use of talimogene laherparepvec in melanoma.

Howard D. Edington, MD

Dr. Edington on the Utilization of TIL Therapy in Melanoma

ByHoward D. Edington, MD

April 21st 2022

Howard D. Edington, MD, discusses the utilization of tumor-infiltrating lymphocyte therapy in melanoma.

Howard D. Edington, MD, director, Cutaneous Oncology Program, Melanoma and Skin Cancer Center, Allegheny Health Network

Dr. Edington on the Importance of Prevention Strategies in Melanoma

ByHoward D. Edington, MD

April 19th 2022

Howard D. Edington, MD, discusses the importance of prevention strategies in melanoma.

Howard D. Edington, MD

Dr. Edington on the Evolving Treatment Paradigm of Melanoma

ByHoward D. Edington, MD

April 12th 2022

Howard D. Edington, MD, discusses the evolving treatment paradigm of melanoma.

Latest Updated Articles

Trending on OncLive

CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026

ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC

Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026

Aglatimagene Besadenovec Plus EBRT Improves Prostate Cancer-Specific DFS

FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer